Fentanyl Transdermal Patch and Abametapir: Interaction Details
- Fentanyl Transdermal Patch
- DuragesicAbstralSubsys +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Abametapir interaction:
Abametapir
We don't have a drug information page for Abametapir because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Abametapir? Ask a pharmacist, free →
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
What Happens When You Take Fentanyl Transdermal Patch With Abametapir
What can happen when they are taken together (rated Major)
Increased exposure of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Do not use CYP3A4 substrates during the 2 weeks that follow abametapir application. When that cannot be done, abametapir should not be used.1
The Fentanyl Transdermal Patch and Abametapir Interaction, Explained
Abametapir (Xeglyze) is a lotion used to treat head lice. Fentanyl patches (Duragesic) are used for strong, ongoing pain. Your body breaks down fentanyl mostly with an enzyme called , and abametapir can slow that enzyme down. That could let more fentanyl build up in your body, which may cause extra drowsiness or slowed breathing.
This is a theoretical concern based on how the drugs work, not on reports of harm. Still, it is taken seriously because fentanyl is a powerful . Please do not stop or change your patch on your own. Talk with your pharmacist or doctor before using abametapir, since your care team can plan the safest approach for you.
Mechanism: Abametapir inhibits , and fentanyl is a CYP3A4 ( N-dealkylation to norfentanyl). may raise fentanyl exposure (, ) and prolong its effect, increasing the risk of toxicity, including and . Fentanyl is active itself, not a , so the direction is increased effect.
- Onset: rapid. Severity: major. Evidence: theoretical (labeling-based, mechanistic).
- Management: avoid CYP3A4 substrates within 2 weeks after abametapir application. If not feasible, avoid abametapir and consider an alternative pediculicide.
- The transdermal depot may extend exposure, so if co-use occurs, monitor closely for sedation and respiratory depression, and individualize fentanyl dosing.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Abametapir Interact
The likely mechanism
of -mediated by abametapir
How to Manage the Fentanyl Transdermal Patch and Abametapir Interaction
The documented advice is to avoid , which includes fentanyl, for 2 weeks after abametapir is applied. If that is not possible, the recommendation is to avoid abametapir.
- Keep wearing your fentanyl patch as prescribed unless your prescriber tells you otherwise.
- Before using abametapir, tell your pharmacist or prescriber that you use a fentanyl patch. They may suggest a different lice treatment.
- If both are used, your care team may adjust and individualize your dose and monitor you more closely.
- Seek help right away for unusual sleepiness, confusion, or slow or shallow breathing.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Abametapir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Fentanyl Transdermal Patch and Abametapir: Common Questions
How serious is the Fentanyl Transdermal Patch and Abametapir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl Transdermal Patch and Abametapir interaction managed?
The documented advice is to avoid , which includes fentanyl, for 2 weeks after abametapir is applied. If that is not possible, the recommendation is to avoid abametapir. Keep wearing your fentanyl patch as prescribed unless your prescriber tells you otherwise. Before using abametapir, tell your pharmacist or prescriber that you use a fentanyl patch. They may suggest a different li… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Fentanyl Transdermal Patch and Abametapir Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Abametapir together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: XEGLYZE(TM) topical lotion, abametapir topical lotion. Dr Reddy’s Laboratories Inc (per FDA), Princeton, NJ, 2020. DailyMed
Other Serious Interactions of Fentanyl Transdermal Patch and Abametapir
Also serious with Abametapir
Also serious with Fentanyl Transdermal Patch
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Abametapir
- Green TeaModerate
- CannabisModerate
- YohimbeModerate
- Black TeaModerate
- Pu-erh TeaModerate
- CocoaModerate
- AdrafinilModerate
- Cannabidiol (CBD)Moderate
- + 14 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.